Skip to main content
Clinical Trials/NCT03824977
NCT03824977
Completed
Not Applicable

Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery

University Hospital, Rouen1 site in 1 country122 target enrollmentNovember 21, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lung Neoplasm Malignant
Sponsor
University Hospital, Rouen
Enrollment
122
Locations
1
Primary Endpoint
occurrence of a post-operative complication grade ≥ 2 on the Clavien-Dindo scale within three months after surgery
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The objective of this study is to evaluate the performances of the Six-Minute Stepper Test (6MST) and Sit To Stand test (STST) to predict post-operative complications after minimally invasive lung cancer resection.

Registry
clinicaltrials.gov
Start Date
November 21, 2018
End Date
February 4, 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Rouen
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Non-small cell lung cancer stage I to II, justifying major resection by VATS or RATS (segmentectomy, lobectomy, pneumonectomy), with or without histological confirmation

Exclusion Criteria

  • Partial or total amputation localized to the lower limb;
  • Weight greater than 100 kg;
  • Orthopedic, vascular or neurological disorders leading to the incapacity of realize the 6MST;
  • Patient under tutorship or curatorship;
  • Pregnant woman.
  • Surgery canceled

Outcomes

Primary Outcomes

occurrence of a post-operative complication grade ≥ 2 on the Clavien-Dindo scale within three months after surgery

Time Frame: 90 days

Study Sites (1)

Loading locations...

Similar Trials